The Effects of Alternate-Day Corticosteroids in Autoimmune Disease Patients.

Genny Margarita Chaia-SemerenaMaría Eugenia Vargas-CamañoCesar Daniel Alonso-BelloJorge Javier Guillén-ToledoRicardo Leopoldo Guido-BayardoFernando Lozano-PatiñoMariano Daniel Temix-DelfínMaría Isabel Castrejón-Vázquez

Published in: Autoimmune diseases (2020)

Treatment with alternate-day corticosteroids achieved a statistically significant decrease in serum autoantibody levels in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
multiple sclerosis
smoking cessation